Literature DB >> 19463267

Geissospermum vellosii stembark: anticholinesterase activity and improvement of scopolamine-induced memory deficits.

Josélia A Lima1, Rodrigo Saar Costa, Rosangela A Epifânio, Newton G Castro, Mônica S Rocha, Angelo C Pinto.   

Abstract

This study evaluated the cholinesterase inhibitory activity of an alkaloid-rich fraction of stembark from Geissospermum vellosii (PP), and its effect on memory tests in mice. PP inhibited rat brain and electric eel acetylcholinesterase, as well as horse serum butyrylcholinesterase in a concentration-dependent manner with mean IC(50) values of 39.3 microg/mL, 2.9 microg/mL, and 1.6 microg/mL, respectively. The main alkaloid with anticholinesterase activity in PP was isolated and identified as geissospermine. PP significantly reduced scopolamine-induced amnesia in the passive avoidance and Morris water maze tests, at 30 mg/kg i.p. (given 45 min before the test sessions). At the highest effective dose (60 mg/kg), administration of PP did not result in noticeable peripheral or central cholinergic side effects. Only after administration of 200 mg/kg, mice showed convulsions affecting the whole body followed by death. These results show that compounds present in G. vellosii stembark have anticholinesterase activity, and that they can revert cognitive deficits in a model of cholinergic hypofunction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19463267     DOI: 10.1016/j.pbb.2009.01.024

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  8 in total

Review 1.  Natural products as a source of Alzheimer's drug leads.

Authors:  Philip Williams; Analia Sorribas; Melanie-Jayne R Howes
Journal:  Nat Prod Rep       Date:  2010-11-12       Impact factor: 13.423

2.  Docking of the alkaloid geissospermine into acetylcholinesterase: a natural scaffold targeting the treatment of Alzheimer's disease.

Authors:  Jocley Queiroz Araújo; Josélia Alencar Lima; Angelo da Cunha Pinto; Ricardo Bicca de Alencastro; Magaly Girão Albuquerque
Journal:  J Mol Model       Date:  2010-09-16       Impact factor: 1.810

3.  Brønsted acid mediated cyclization of enaminones. Rapid and efficient access to the tetracyclic framework of the Strychnos alkaloids.

Authors:  Rahul V Edwankar; Chitra R Edwankar; Ojas A Namjoshi; Jeffrey R Deschamps; James M Cook
Journal:  J Nat Prod       Date:  2012-01-18       Impact factor: 4.050

4.  Donepezil HCl Liposomes: Development, Characterization, Cytotoxicity, and Pharmacokinetic Study.

Authors:  Amarjitsing Rajput; Shital Butani
Journal:  AAPS PharmSciTech       Date:  2022-02-11       Impact factor: 3.246

5.  Evaluation of larvicidal, adulticidal, and anticholinesterase activities of essential oils of Illicium verum Hook. f., Pimenta dioica (L.) Merr., and Myristica fragrans Houtt. against Zika virus vectors.

Authors:  Diego Gomes da Rocha Voris; Luciana Dos Santos Dias; Josélia Alencar Lima; Keila Dos Santos Cople Lima; José Bento Pereira Lima; Antônio Luís Dos Santos Lima
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-28       Impact factor: 5.190

6.  Natural AChE Inhibitors from Plants and their Contribution to Alzheimer's Disease Therapy.

Authors:  Ana Paula Murray; María Belén Faraoni; María Julia Castro; Natalia Paola Alza; Valeria Cavallaro
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

7.  Synthesis of New Quinoline-Piperonal Hybrids as Potential Drugs against Alzheimer's Disease.

Authors:  Juliana de Oliveira C Brum; Denise Cristian F Neto; Joyce Sobreiro F D de Almeida; Josélia Alencar Lima; Kamil Kuca; Tanos Celmar C França; José D Figueroa-Villar
Journal:  Int J Mol Sci       Date:  2019-08-14       Impact factor: 5.923

8.  Geissospermiculatine, a New Alkaloid from Geissospermum reticulatum Bark.

Authors:  Joanna J Sajkowska-Kozielewicz; Paweł Kozielewicz; Katerina Makarova; Marcin Stocki; Nicholas M Barnes; Katarzyna Paradowska
Journal:  Molecules       Date:  2020-12-31       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.